|
1
|
Attanoos R: Lung cancer associated with
asbestos exposure. Asbestos and Its Diseases. Craighead JE and
Gibbs AR: Oxford University Press; New York: pp. 172–189. 2008,
View Article : Google Scholar
|
|
2
|
Hammar SP: Asbestos and mesothelioma.
Sebstos; Risk Assessment, Epidemiology, and Health Effects. Dodson
RF and Hammar SP: 2nd. CRC Press; Boca Raton, FL: pp. 307–418.
2011, View
Article : Google Scholar
|
|
3
|
Asbestos and Mesothelioma (Current Cancer
Research). Testa JR: Springer International Publishing;
Gewerbestrasse, Switzerland: 2017
|
|
4
|
International Agency for Research on
Cancer. A review of human carcinogens: Arsenic, metals, fibres, and
dusts (iarc monographs on the evaluation of the carcinogenic risks
to humans). WHO Press; Lyon, France: 2012
|
|
5
|
Shukla A, Gulumian M, Hei TK, Kamp D,
Rahman Q and Mossman BT: Multiple roles of oxidants in the
pathogenesis of asbestos-induced diseases. Free Radic Biol Med.
34:1117–1129. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Upadhyay D and Kamp DW: Asbestos-induced
pulmonary toxicity: Role of DNA damage and apoptosis. Exp Biol Med.
228:650–659. 2003. View Article : Google Scholar
|
|
7
|
Liu X and Chen Z: The pathophysiological
role of mitochondrial oxidative stress in lung diseases. J Transl
Med. 15:2072017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Simeonova PP and Luster MI: Iron and
reactive oxygen species in the asbestos-induced tumor necrosis
factor-alpha response from alveolar macrophages. Am J Respir Cell
Mol Biol. 12:676–683. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Boyles MS, Young L, Brown DM, MacCalman L,
Cowie H, Moisala A, Smail F, Smith PJ, Proudfoot L, Windle AH, et
al: Multi-walled carbon nanotube induced frustrated phagocytosis,
cytotoxicity and pro-inflammatory conditions in macrophages are
length dependent and greater than that of asbestos. Toxicol In
Vitro. 29:1513–1528. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Toyokuni S: Mechanisms of asbestos-induced
carcinogenesis. Nagoya J Med Sci. 71:1–10. 2009.PubMed/NCBI
|
|
11
|
Chew SH and Toyokuni S: Malignant
mesothelioma as an oxidative stress-induced cancer: An update. Free
Radic Biol Med. 86:166–178. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Otsuki T, Maeda M, Murakami S, Hayashi H,
Miura Y, Kusaka M, Nakano T, Fukuoka K, Kishimoto T, Hyodoh F, et
al: Immunological effects of silica and asbestos. Cell Mol Immunol.
4:261–268. 2007.PubMed/NCBI
|
|
13
|
Kumagai-Takei N, Maeda M, Chen Y,
Matsuzaki H, Lee S, Nishimura Y, Hiratsuka J and Otsuki T: Asbestos
induces reduction of tumor immunity. Clin Dev Immunol.
2011:4814392011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Otsuki T, Matsuzaki H, Lee S,
Kumagai-Takei N, Yamamoto S, Hatayama T, Yoshitome K and Nishimura
Y: Environmental factors and human health: Fibrous and particulate
substance-induced immunological disorders and construction of a
health-promoting living environment. Environ Health Prev Med.
21:71–81. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nishimura Y, Miura Y, Maeda M, Kumagai N,
Murakami S, Hayashi H, Fukuoka K, Nakano T and Otsuki T: Impairment
in cytotoxicity and expression of NK cell-activating receptors on
human NK cells following exposure to asbestos fibers. Int J
Immunopathol Pharmacol. 22:579–590. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nishimura Y, Maeda M, Kumagai N, Hayashi
H, Miura Y and Otsuki T: Decrease in phosphorylation of ERK
following decreased expression of NK cell-activating receptors in
human NK cell line exposed to asbestos. Int J Immunopathol
Pharmacol. 22:879–888. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kumagai-Takei N, Nishimura Y, Maeda M,
Hayashi H, Matsuzaki H, Lee S, Hiratsuka J and Otsuki T: Effect of
asbestos exposure on differentiation of cytotoxic T lymphocytes in
mixed lymphocyte reaction of human peripheral blood mononuclear
cells. Am J Respir Cell Mol Biol. 49:28–36. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Maeda M, Nishimura Y, Hayashi H, Kumagai
N, Chen Y, Murakami S, Miura Y, Hiratsuka J, Kishimoto T and Otsuki
T: Reduction of CXC chemokine receptor 3 in an in vitro model of
continuous exposure to asbestos in a human T-cell line, MT-2. Am J
Respir Cell Mol Biol. 45:470–479. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Maeda M, Nishimura Y, Hayashi H, Kumagai
N, Chen Y, Murakami S, Miura Y, Hiratsuka J, Kishimoto T and Otsuki
T: Decreased CXCR3 expression in CD4+ T cells exposed to
asbestos or derived from asbestos-exposed patients. Am J Respir
Cell Mol Biol. 45:795–803. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen X, Du Y, Lin X, Qian Y, Zhou T and
Huang Z: CD4 + CD25 + regulatory T cells in tumor immunity. Int
Immunopharmacol. 34:244–249. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Szylberg Ł, Karbownik D and Marszałek A:
The role of foxP3 in human cancers. Anticancer Res. 36:3789–3794.
2016.PubMed/NCBI
|
|
22
|
Tanaka A and Sakaguchi S: Regulatory T
cells in cancer immunotherapy. Cell Res. 27:109–118. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hamano R, Wu X, Wang Y, Oppenheim JJ and
Chen X: Characterization of MT-2 cells as a human regulatory T
cell-like cell line. Cell Mol Immunol. 12:780–782. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen S1, Ishii N, Ine S, Ikeda S, Fujimura
T, Ndhlovu LC, Soroosh P, Tada K, Harigae H, Kameoka J, et al:
Regulatory T cell-like activity of Foxp3+ adult T cell
leukemia cells. Int Immunol. 18:269–277. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hyodoh F, Takata-Tomokuni A, Miura Y,
Sakaguchi H, Hatayama T, Hatada S, Katsuyama H, Matsuo Y and Otsuki
T: Inhibitory effects of anti-oxidants on apoptosis of a human
polyclonal T-cell line, MT-2, induced by an asbestos, chrysotile-A.
Scand J Immunol. 61:442–448. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Miura Y, Nishimura Y, Katsuyama H, Maeda
M, Hayashi H, Dong M, Hyodoh F, Tomita M, Matsuo Y, Uesaka A, et
al: Involvement of IL-10 and Bcl-2 in resistance against an
asbestos-induced apoptosis of T cells. Apoptosis. 11:1825–1835.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Maeda M, Yamamoto S, Chen Y, Kumagai-Takei
N, Hayashi H, Matsuzaki H, Lee S, Hatayama T, Miyahara N, Katoh M,
et al: Resistance to asbestos-induced apoptosis with continuous
exposure to crocidolite on a human T cell. Sci Total Environ.
429:174–182. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Maeda M, Chen Y, Hayashi H, Kumagai-Takei
N, Matsuzaki H, Lee S, Nishimura Y and Otsuki T: Chronic exposure
to asbestos enhances TGF-β1 production in the human adult T cell
leukemia virus-immortalized T cell line MT-2. Int J Oncol.
45:2522–2532. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ying C, Maeda M, Nishimura Y,
Kumagai-Takei N, Hayashi H, Matsuzaki H, Lee S, Yoshitome K,
Yamamoto S, Hatayama T and Otsuki T: Enhancement of regulatory T
cell-like suppressive function in MT-2 by long-term and low-dose
exposure to asbestos. Toxicology. 338:86–94. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Matsuzaki H, Lee S, Maeda M, Kumagai-Takei
N, Nishimura Y and Otsuki T: FoxO1 regulates apoptosis induced by
asbestos in the MT-2 human T-cell line. J Immunotoxicol.
13:620–627. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lee S, Matsuzaki H, Maeda M, Yamamoto S,
Kumagai-Takei N, Hatayama T, Ikeda M, Yoshitome K, Nishimura Y and
Otsuki T: Accelerated cell cycle progression of human regulatory T
cell-like cell line caused by continuous exposure to asbestos
fibers. Int J Oncol. 50:66–74. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Maeda M, Yamamoto S, Hatayama T, Matsuzaki
H, Lee S, Kumagai-Takei N, Yoshitome K, Nishimura Y, Kimura Y and
Otsuki T: T cell alteration caused by exposure to asbestos.
Biological Effects of Fibrous and Particulate Substances. Otsuki T,
Holian A and Yoshioka Y: Springer; Japan, Tokyo: pp. 195–210.
2015
|
|
33
|
Kohyama N, Shinohara Y and Suzuki Y:
Mineral phases and some reexamined characteristics of the
international union against cancer standard asbestos samples. Am J
Ind Med. 30:515–528. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Boden E, Tang Q, Bour-Jordan H and
Bluestone JA: The role of CD28 and CTLA4 in the function and
homeostasis of CD4+CD25+ regulatory T cells. Novartis Found Symp.
252:55–63. 2003.PubMed/NCBI
|
|
35
|
Ko K, Yamazaki S, Nakamura K, Nishioka T,
Hirota K, Yamaguchi T, Shimizu J, Nomura T, Chiba T and Sakaguchi
S: Treatment of advanced tumors with agonistic anti-GITR mAb and
its effects on tumor-infiltrating
Foxp3+CD25+CD4+ regulatory T
cells. J Exp Med. 202:885–891. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Thornton AM, Korty PE, Tran DQ, Wohlfert
EA, Murray PE, Belkaid Y and Shevach EM: Expression of Helios, an
Ikaros transcription factor family member, differentiates
thymic-derived from peripherally induced Foxp3+ T
regulatory cells. J Immunol. 184:3433–3441. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Grzanka J, Leveson-Gower D, Golab K, Wang
XJ, Marek-Trzonkowska N, Krzystyniak A, Wardowska A, Mills JM,
Trzonkowski P and Witkowski P: FoxP3, Helios, and SATB1: Roles and
relationships in regulatory T cells. Int Immunopharmacol.
16:343–347. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ono M, Yaguchi H, Ohkura N, Kitabayashi I,
Nagamura Y, Nomura T, Miyachi Y, Tsukada T and Sakaguchi S: Foxp3
controls regulatory T-cell function by interacting with AML1/Runx1.
Nature. 446:685–689. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Maeda M, Chen Y, Lee S, Kumagai-Takei N,
Yoshitome K, Matsuzaki H, Yamamoto S, Hatayama T, Ikeda M,
Nishimura Y and Otsuki T: Induction of IL-17 production from human
peripheral blood CD4+ cells by asbestos exposure. Int J
Oncol. 50:2024–2032. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kumagai-Takei N, Nishimura Y, Maeda M,
Hayashi H, Matsuzaki H, Lee S, Kishimoto T, Fukuoka K, Nakano T and
Otsuki T: Functional properties of CD8+ lymphocytes in
patients with pleural plaque and malignant mesothelioma. J Immunol
Res. 2014:6701402014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Maeda M, Chen Y, Kumagai-Takei N, Hayashi
H, Matsuzaki H, Lee S, Hiratsuka J, Nishimura Y, Kimura Y and
Otsuki T: Alteration of cytoskeletal molecules in a human T cell
line caused by continuous exposure to chrysotile asbestos.
Immunobiology. 218:1184–1191. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang L, Tao R and Hancock WW: Using
histone deacetylase inhibitors to enhance Foxp3+
regulatory T-cell function and induce allograft tolerance. Immunol
Cell Biol. 87:195–202. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bennett MK and Kirk CJ: Development of
proteasome inhibitors in oncology and autoimmune diseases. Curr
Opin Drug Discov Devel. 11:616–625. 2008.PubMed/NCBI
|
